Latest News

08.23.19

Iconic Therapeutics Signs Ophthalmology Option Agreement With Novartis

Source: Iconic Therapeutics

08.23.19

High Levels of Exhaust Pollutants May Raise Risk for AMD

Source: Reuters

08.22.19

Clearside Biomedical Provides New Drug Application Update for Xipere

Source: Clearside Biomedical

08.20.19

Orbis Celebrates New Data Showing a 91% Reduction in Populations at Risk of Blinding Trachoma in Endemic Areas

Source: Orbis International

08.20.19

Oxurion Reports Topline Month 3 Results of Phase 2a Study Evaluating THR-317 in Combination with Ranibizumab for DME

Source: Oxurion NV

08.20.19

Examining the Role of Vitamin B3 Supplementation in Reducing and Preventing Retinal Cell Damage Caused by Glaucoma

Source: Fight for Sight

08.20.19

Nidek Launches the Mirante Scanning Laser Ophthalmoscope

Source: Nidek

08.20.19

Aerie Pharmaceuticals Initiates First-in-Human Clinical Trial of AR-13503 Sustained Release Intravitreal Implant in Patients with Wet AMD and DME

Source: Aerie Pharmaceuticals

08.19.19

American Journal of Ophthalmology Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)

Source: Horizon Therapeutics

08.16.19

Trial of Tele-Ophthalmology System at Regional Health Board in Scotland Shows Promising Results

Source: HealthCare IT News

View more stories